Stoke Therapeutics Inc buy Chardan Capital

Summary

This prediction is currently active. With a performance of -4.66%, the BUY prediction for Stoke Therapeutics Inc by Chardan_Capital is down slightly. This prediction currently runs until 18.03.27. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Stoke Therapeutics Inc	-	-
iShares Core DAX®	0,85 %	0,39 %
iShares Nasdaq 100	-0,99 %	-4,40 %
iShares Nikkei 225®	-1,78 %	-11,22 %
iShares S&P 500	0,06 %	0,78 %